Cargando…

CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma

Malignant mesothelioma is a cancer with a poor survival rate. It is difficult to diagnose mesotheliomas because they show a variety of histological patterns similar to those of various other cancers. However, since currently used positive markers for mesotheliomas may show false positives or false n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, Masayuki, Higashi, Tomohito, Ozeki, Kana, Higashi, Atsuko Y., Sugimoto, Kotaro, Mine, Hayato, Takagi, Hironori, Ozaki, Yuki, Muto, Satoshi, Okabe, Naoyuki, Matsumura, Yuki, Hasegawa, Takeo, Shio, Yutaka, Suzuki, Hiroyuki, Chiba, Hideki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206149/ https://www.ncbi.nlm.nih.gov/pubmed/34131154 http://dx.doi.org/10.1038/s41598-021-91464-0

Ejemplares similares

Our experience of lung resection in patients who decline blood transfusion for religious reasons
por: Takagi, Hironori, et al.
Publicado: (2021)

Pulmonary large cell carcinoma, highly positive for PD‐L1, shows marked response to pembrolizumab: A case report
por: Okabe, Naoyuki, et al.
Publicado: (2021)

Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report
por: Watanabe, Masayuki, et al.
Publicado: (2022)

Thoracoscopic resection of posterior mediastinal paraganglioma: perioperative management and surgical tips
por: Matsumura, Yuki, et al.
Publicado: (2022)

A patient with ALK‐positive lung adenocarcinoma who survived alectinib‐refractory postoperative recurrence for 4 years by switching to ceritinib
por: Matsumura, Yuki, et al.
Publicado: (2021)

Successful Treatment of Combined Large Cell Neuroendocrine Carcinoma Harboring an EGFR Mutation with EGFR-TKIs plus Bevacizumab: A Case Report
por: Muto, Satoshi, et al.
Publicado: (2020)

Diffuse Cystic Metastases in the Lung after Nivolumab Treatment in a Patient with Non-Small Cell Lung Cancer: A Case Report
por: Muto, Satoshi, et al.
Publicado: (2021)

Claudin-9 constitutes tight junctions of folliculo-stellate cells in the anterior pituitary gland
por: Higashi, Atsuko Y., et al.
Publicado: (2021)

Ectopic adrenocorticotropic hormone‐secreting carcinoid with solitary cryptococcosis in the lungs
por: Takagi, Hironori, et al.
Publicado: (2022)

Tumor β-catenin expression is associated with immune evasion in non-small cell lung cancer with high tumor mutation burden
por: Muto, Satoshi, et al.
Publicado: (2021)

Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers
por: Muto, Satoshi, et al.
Publicado: (2023)

Lung adenocarcinoma coexisting with diffuse idiopathic pulmonary neuroendocrine cell hyperplasia manifesting as multiple pulmonary nodules: A case report
por: Inomata, Sho, et al.
Publicado: (2022)

The Src-Family Kinases SRC and BLK Contribute to the CLDN6-Adhesion Signaling
por: Ichikawa-Tomikawa, Naoki, et al.
Publicado: (2023)

Nivolumab-related severe thrombocytopenia in a patient with relapsed lung adenocarcinoma: a case report and review of the literature
por: Hasegawa, Takeo, et al.
Publicado: (2019)

Garcin syndrome caused by sphenoid bone metastasis of lung cancer: a case study
por: Fukai, Satoshi, et al.
Publicado: (2018)

Family with sequence similarity 83, member B is a predictor of poor prognosis and a potential therapeutic target for lung adenocarcinoma expressing wild-type epidermal growth factor receptor
por: Yamaura, Takumi, et al.
Publicado: (2018)

The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study protocol for a randomized controlled trial
por: Inoue, Takuya, et al.
Publicado: (2017)

Claudin-9 is a novel prognostic biomarker for endometrial cancer
por: Endo, Yuta, et al.
Publicado: (2022)

Malignant Peritoneal Mesothelioma Presenting with Polymyalgia Rheumatica-like Syndrome
por: Ide, Yuka, et al.
Publicado: (2020)

EpCAM proteolysis and release of complexed claudin-7 repair and maintain the tight junction barrier
por: Higashi, Tomohito, et al.
Publicado: (2022)

Serotonin/5-HT1A Signaling in the Neurovascular Unit Regulates Endothelial CLDN5 Expression
por: Sugimoto, Kotaro, et al.
Publicado: (2020)

Occludin and tricellulin facilitate formation of anastomosing tight-junction strand network to improve barrier function
por: Saito, Akira C., et al.
Publicado: (2021)

Prognostic Impact of Hypoxia-Inducible miRNA-210 in Patients with Lung Adenocarcinoma
por: Osugi, Jun, et al.
Publicado: (2015)

Successful Management of Crizotinib-Induced Neutropenia in a Patient with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Case Report
por: Osugi, Jun, et al.
Publicado: (2016)

Clinical significance of expanded Foxp3(+) Helios(−) regulatory T cells in patients with non-small cell lung cancer
por: MUTO, SATOSHI, et al.
Publicado: (2015)

Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma
por: Zhang, Zhenfa, et al.
Publicado: (2013)

Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications
por: Kwon, Mi Jeong, et al.
Publicado: (2010)

Association of CLDN6 and CLDN10 With Immune Microenvironment in Ovarian Cancer: A Study of the Claudin Family
por: Gao, Peipei, et al.
Publicado: (2021)

Preclinical Evaluation of Podoplanin-Targeted Alpha-Radioimmunotherapy with the Novel Antibody NZ-16 for Malignant Mesothelioma
por: Sudo, Hitomi, et al.
Publicado: (2021)

Chondrosarcoma of the Rib Mimicking Malignant Pleural Mesothelioma
por: Furukawa, Masashi, et al.
Publicado: (2016)

The Expression of CLDN6 in Hepatocellular Carcinoma Tissue and the Effects of CLDN6 on Biological Phenotypes of Hepatocellular Carcinoma Cells
por: Lu, Yan, et al.
Publicado: (2021)

CD7 Expression in Malignant Pleural Mesothelioma
por: Hibi, Shigeyoshi, et al.
Publicado: (1992)

The IL1β-HER2-CLDN18/CLDN4 axis mediates lung barrier damage in ARDS
por: Ma, Xinhua, et al.
Publicado: (2020)

Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
por: McDermott, Martina S.J., et al.
Publicado: (2023)

Functional image guided radiation therapy planning in volumetric modulated arc therapy for patients with malignant pleural mesothelioma
por: Doi, Yoshiko, et al.
Publicado: (2017)

A case of discordant histology and expression of programmed death ligand 1 between primary tumor and brain metastases in adenosquamous carcinoma of the lung
por: Takagi, Hironori, et al.
Publicado: (2023)

Tricellular junctions: how to build junctions at the TRICkiest points of epithelial cells
por: Higashi, Tomohito, et al.
Publicado: (2017)

ZO-1 Knockout by TALEN-Mediated Gene Targeting in MDCK Cells: Involvement of ZO-1 in the Regulation of Cytoskeleton and Cell Shape
por: Tokuda, Shinsaku, et al.
Publicado: (2014)

Mutations in CLDN14 are associated with different hearing thresholds
por: Bashir, Rasheeda, et al.
Publicado: (2010)

Polymorphism of the CLDN5 gene and Schizophrenia in an Iranian Population
por: OMIDINIA, Eskandar, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fv0eq1i6h23hh3c9gk15o5bsci